Carl Gordon Net Worth & Insider Trades

Carl Gordon - Director, Kinnate Biopharma Inc

As of June 15, 2022

What is Carl Gordon's Net Worth?

The current estimated net worth of Kinnate Biopharma Inc's Director, Carl Gordon, is estimated to be about $961.74M . Carl Gordon owns about 3,959,030 units of Kinnate Biopharma Inc common stock. In the last 2 years at Kinnate Biopharma Inc, Carl Gordon has sold an estimated value of $0 worth.

What is Carl Gordon's Past Insider Trading?

Carl Gordon's largest purchase order was 750,000 units , worth over $15M on December 4, 2020. In total, Carl Gordon has made about 5 transactions over 2 years of their time at Kinnate Biopharma Inc. Carl Gordon usually trades in December, with the busiest year in 2020. The most recent transaction was a purchase order of 195,700 units , worth over $1.99M on February 15, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Carl Gordon's' Mailing Address?

  • Mailing address is 601 Lexington Avenue 54th Floor New York NY 10022 NY

Kinnate Biopharma Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nima Farzan 2020 $359,423 - $4,370,048 - $329 $4,945,454
Nima Farzan 2019 - - - - - -
Mark Meltz 2020 $267,173 - $1,268,433 - $392392 $1,676,264
Mark Meltz 2019 - - - - - -
Eric Murphy, Ph.D. 2020 $376,115 - $983,188983,188 - $447 $1,529,002
Eric Murphy, Ph.D. 2019 $336,156 - - - $344 $403,775403,775
Steve Kaldor, Ph.D. 2020 $84,172 84,172 - - - $23,249 $107,421 107,421
Steve Kaldor, Ph.D. 2019 $336,156 $67,275 67,275 - $67,275 67,275 $1,481 1,481 $404,912404,912
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1797768/000114036121015081/nc10022093x1_def14a.htm

What are Kinnate Biopharma Inc's Past Insider Trades?

Kinnate Biopharma Inc's most recent insider trade came on March 15, 2022 by Thomas Richard Williams who bought 40,000 units worth $338.85K . In the last 2 years, insiders at Kinnate Biopharma Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Carl Gordon, Director,  James Tananbaum, Director,  and Orbimed Advisors Llc, Director .

Kinnate Biopharma Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1